Evidence map›Paper›PMID 42014790›Full record

ArticleScientific reports2026

A multipurpose 1DZnO nanoplatform to combat ampicillin-resistant E. coli.

Shirlley E Martínez Tolibia, Citlaly Gutiérrez Rodelo, Rafael Salinas Domínguez, Laura J García Barrera, Rogelio Zapata Arenas, Juliana Gutiérrez Rodelo, Andrés Navarrete, Ateet Dutt

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shirlley E Martínez Tolibia *Departament of Low Dimensionality Materials, Materials Research Institute, National Autonomous University of Mexico, 04510, Mexico City, Mexico.
Citlaly Gutiérrez Rodelo *Departament of Pharmacy, Faculty of Chemistry, National Autonomous University of Mexico, 04510, Mexico City, Mexico.
Rafael Salinas Domínguez *Departament of Low Dimensionality Materials, Materials Research Institute, National Autonomous University of Mexico, 04510, Mexico City, Mexico.
Laura J García BarreraResearch Center in Applied Biotechnology, National Polytechnic Institute (CIBA-IPN), 90700, Tlaxcala, México.
Rogelio Zapata ArenasDepartment of Internal Medicine, General Hospital of Mexico, 06720, Mexico City, Mexico.
Juliana Gutiérrez RodeloMexican Social Security Institute, General Hospital of Subzone No. 4 (IMSS), 80370, Sinaloa, México.
Andrés NavarreteDepartament of Pharmacy, Faculty of Chemistry, National Autonomous University of Mexico, 04510, Mexico City, Mexico.
Ateet DuttDepartament of Low Dimensionality Materials, Materials Research Institute, National Autonomous University of Mexico, 04510, Mexico City, Mexico. adutt@iim.unam.mx.

Funding

Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México IA209426Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México IN100125Secretaría de Estado de Ciencia, Tecnología e Innovación 5159c25
6 · The paper itself

Abstract

Nanomaterials can provide versatile alternatives for accurate biodetection and treatment to prevent the rapid propagation of antimicrobial-resistant (AMR) microorganisms. Nevertheless, a characterization of their global effects must be conducted before management and experimental use, particularly for in vivo applications. In this work, we evaluated the multifunctional properties of one-dimensional ZnO nanowires (ZnO NWs) for optical biodetection of ampicillin-resistant Escherichia coli (ampr-E. coli). In addition, we assessed the antibacterial effects against these bacteria and biocompatibility after interaction with mammalian cells, providing new insights into the novel functionalities of ZnO NWs. From our experimental design, we obtained quenching of photoluminescence (PL) after 10 s of contact with biofunctionalized ZnO NWs across bacterial concentrations of 10

Indexed as

Ampicillin ResistanceAnti-Bacterial AgentsEscherichia coliNanowiresZinc OxideAmpicillinHEK293 CellsHumansMicrobial Sensitivity TestsAmpicillinAnti-Bacterial AgentsZinc OxideAmpicillin-resistant E. coliAntibacterial assessmentAntibiotic resistanceHEK-293 cellsOptical detectionZnO nanowires

Identifiers

PMID42014790
PMCPMC13265761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.